KIM MILLER: Open Payments
NPI 1215285424 · CLYDE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 30 payments from 13 companies in 2025. Trend: 2023 $272 · 2024 $494 · 2025 $552
Food & beverage: $453Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $200 |
| ABBVIE INC. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Abbott Laboratories | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| PFIZER INC. | 2 | $30 |
| Lundbeck LLC | 2 | $29 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
Products named: AUSTEDO XR, VRAYLAR, INGREZZA, FREESTYLE LIBRE 3, Auvelity, NURTEC ODT, REXULTI, FARXIGA.
Industry payments across OH — which companies pay providers there.
